RNA Therapeutics market Analysis and Trends by 2023-2035
More than 100 next generation RNA therapeutics and vaccines are being developed to offer an advanced, low-dose form of treatment, targeting a wide range of therapeutic indications
The traditional RNA-based therapies are known to be associated with various stability and delivery-related challenges. This has prompted industry stakeholders to modify such therapies to develop next generation therapies with enhanced stability and self-replicating capability. Further, the development of novel technologies for the development and delivery of such therapies has escalated the interest of industry stakeholders in enhanced and modified RNA-based therapies. The next generation RNA therapies domain is anticipated to evolve rapidly to become the next big therapeutic segment in the coming decade.
§ The financial opportunity associated with RNA Therapeutics and RNA Vaccines Market has been analyzed across the following segments:
§ Type of Modality
§ Therapeutics
§ Vaccines
§ Type of Molecule
§ Replicating RNA (repRNA)
§ Self amplifying RNA (saRNA)
§ Self activating RNA (sacRNA)
§ Self activating mRNA (sa-mRNA)
§ Transfer RNA (tRNA)
§ Therapeutic Area
§ Infectious Diseases
§ Oncological Disorders
§ Pulmonary Disorders
§ Route of Administration
§ Intradermal
§ Intramuscular
§ Intravenous
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Leading Industry Players
§ Alphavax
§ Company 1
§ Company 2
§ Company 3
The RNA Therapeutics and RNA Vaccines Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
§ Alphavax
§ Arcturus Therapeutics
§ Atyr Pharma
§ Gritstone Bio
§ HDT Bio
§ MiNA Therapeutics
§ VLP Therapeutics
Table of Contents
1. PREFACE
2. RESEARCH METHODOLOGY
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4. EXECUTIVE SUMMARY
5. INTRODUCTION
6. MARKET LANDSCAPE
7. TECHNOLOGY LANDSCAPE
8. DRUG PROFILES
9. CLINICAL TRIAL ANALYSIS
10. PATENT ANALYSIS
11. PARTNERSHIPS AND COLLABORATIONS
12. FUNDING AND INVESTMENT ANALYSIS
13. BIG PHARMA INITIATIVES
14. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, 2023-2035
15. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY TYPE OF MODALITY
16. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY TYPE OF MOLECULE
17. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY THERAPEUTIC AREA
18. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY ROUTE OF ADMINISTRATION
19. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY KEY GEOGRAPHICAL REGIONS
20. OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY LEADING PLAYERS
21. CONCLUSION
22. APPENDIX 1: TABULATED DATA
23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/rna-therapeutics-market.html
News article
Antibody Drug Conjugate Market
Learn from experts: do you know about these emerging industry trends?
Transformation of Biopharmaceuticals Manufacturing Through Single-use Bioreactors
Liposome: A Novel Drug Delivery System
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
English